Royal Bank of Canada
MRNA icon

Royal Bank of Canada’s Moderna MRNA Stock Holding History

Royal Bank of Canada’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,000
Closed -$802K – 7111
2024
Q3 		$802K Buy
+12,000
New +$1.1M ﹤0.01% 3720
2021
Q3 		– Sell
-5,000
Closed -$1.18M – 7775
2021
Q2 		$1.18M Buy
+5,000
New +$894K ﹤0.01% 3508
2021
Q1 		– Sell
-10,000
Closed -$1.04M – 7593
2020
Q4 		$1.04M Buy
+10,000
New +$1.01M ﹤0.01% 3448

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's MRNA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Moderna (MRNA) stake by 13% in Q1 2026, selling an estimated $6.74M and leaving 999,340 shares worth $50.8M. The position accounts for 0.01% of the portfolio, ranked #908.

Royal Bank of Canada first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $171M in Q4 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Royal Bank of Canada held 999,340 shares of Moderna worth $50.8M as of Q1 2026.
  • Royal Bank of Canada sold 144,440 Moderna shares in Q1 2026, an estimated $6.74M.
  • Moderna made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #908 holding.
  • Royal Bank of Canada first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
  • Royal Bank of Canada's Moderna position peaked at $171M in Q4 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.